Masafumi Fukagawa - Search Results

This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Save citations to file

Email citations

Subject: Masafumi Fukagawa - PubMed

To:

From:

Selection:

Format:

MeSH and other data

Add to Collections

Add to My Bibliography

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Results by year

Year	Number of Results
2002	17
2003	15
2004	15
2005	25
2006	17
2007	19
2008	33
2009	28
2010	19
2011	34
2012	25
2013	34
2014	22
2015	21
2016	24
2017	36
2018	28
2019	35
2020	32
2021	30
2022	27
2023	27
2024	11

502 results

Page of 51

Results by year

Page 1

Effectiveness of calcimimetics on fractures in dialysis patients with secondary hyperparathyroidism: meta-analysis of randomized trials.

Wakamatsu T, Yamamoto S, Matsuo K, Taniguchi M, Hamano T, Fukagawa M, Kazama JJ. Wakamatsu T, et al. Among authors: fukagawa m. J Bone Miner Metab. 2024 Mar 27. doi: 10.1007/s00774-024-01500-y. Online ahead of print. J Bone Miner Metab. 2024. PMID: 38536478

Association of serum sodium levels with fractures and mortality in patients undergoing maintenance hemodialysis.

Soeda K, Komaba H, Nakagawa Y, Kawabata C, Wada T, Takahashi H, Takahashi Y, Hyodo T, Hida M, Suga T, Kakuta T, Fukagawa M. Soeda K, et al. Among authors: fukagawa m. J Nephrol. 2024 Mar 21. doi: 10.1007/s40620-024-01904-z. Online ahead of print. J Nephrol. 2024. PMID: 38512372

Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies.

Nakai K, Kono K, Yamada S, Taniguchi M, Hamano T, Fukagawa M. Nakai K, et al. Among authors: fukagawa m. Ther Apher Dial. 2024 Mar 18. doi: 10.1111/1744-9987.14125. Online ahead of print. Ther Apher Dial. 2024. PMID: 38499495

Effect of aspirin on cardiovascular events in patients undergoing hemodialysis with hyperphosphatemia: A post hoc analysis of the LANDMARK trial.

Kato M, Ito H, Yamakawa A, Kagimura T, Fukagawa M, Yamamoto M, Saito Y, Akizawa T, Ogata H. Kato M, et al. Among authors: fukagawa m. Ther Apher Dial. 2024 Mar 12. doi: 10.1111/1744-9987.14123. Online ahead of print. Ther Apher Dial. 2024. PMID: 38471797

Associations of vitamin D receptor activators and calcimimetics with falls and effect modifications by physical activity: A prospective cohort study on the Japan Dialysis Outcomes and Practice Patterns Study.

Murashima M, Yamamoto R, Kanda E, Kurita N, Noma H, Hamano T, Fukagawa M. Murashima M, et al. Among authors: fukagawa m. Ther Apher Dial. 2024 Mar 10. doi: 10.1111/1744-9987.14122. Online ahead of print. Ther Apher Dial. 2024. PMID: 38462749

The impact of low and high dialysate calcium concentrations on cardiovascular disease and death in patients undergoing maintenance hemodialysis: a systematic review and meta-analysis.

Kamei K, Yamada S, Hashimoto K, Konta T, Hamano T, Fukagawa M. Kamei K, et al. Among authors: fukagawa m. Clin Exp Nephrol. 2024 Feb 24. doi: 10.1007/s10157-024-02460-3. Online ahead of print. Clin Exp Nephrol. 2024. PMID: 38396314

Slope of the estimated glomerular filtration rate and its associated factors among individuals with chronic kidney disease in the general Japanese population.

Ito J, Fukagawa M. Ito J, et al. Among authors: fukagawa m. Clin Exp Nephrol. 2024 Feb 10. doi: 10.1007/s10157-024-02466-x. Online ahead of print. Clin Exp Nephrol. 2024. PMID: 38340246

Residual kidney function modifies the effect of cinacalcet on serum phosphorus levels among peritoneal dialysis patients.

Murashima M, Fujii N, Goto S, Hasegawa T, Abe M, Hanafusa N, Fukagawa M, Hamano T. Murashima M, et al. Among authors: fukagawa m. J Nephrol. 2024 Jan 27. doi: 10.1007/s40620-023-01863-x. Online ahead of print. J Nephrol. 2024. PMID: 38280094 No abstract available.

Phase 2 study of upacicalcet in Japanese haemodialysis patients with secondary hyperparathyroidism: an intraindividual dose-adjustment study.

Inaguma D, Koiwa F, Tokumoto M, Fukagawa M, Yoneda S, Yasuzawa H, Asano K, Hagita K, Inagaki Y, Honda D, Akizawa T. Inaguma D, et al. Among authors: fukagawa m. Clin Kidney J. 2023 Sep 4;16(12):2614-2625. doi: 10.1093/ckj/sfad213. eCollection 2023 Dec. Clin Kidney J. 2023. PMID: 38045997 Free PMC article.

Comparison of the Oral Calcimimetics Evocalcet and Cinacalcet in East Asian Patients on Hemodialysis with Secondary Hyperparathyroidism.

Ni Z, Liang X, Wu CC, Jin K, Kim YL, Lu KC, Chan TM, Fukagawa M, Kinoshita J, Nagai C, Kojima M, Yu X; Orchestra Study Group. Ni Z, et al. Among authors: fukagawa m. Kidney Int Rep. 2023 Aug 29;8(11):2294-2306. doi: 10.1016/j.ekir.2023.08.034. eCollection 2023 Nov. Kidney Int Rep. 2023. PMID: 38025238 Free PMC article.

502 results

Page of 51

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

502 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

502 results

Results by year